U.S. Food and Drug Administration
Dr. Ahmed Zidan is a senior principle investigator in the CDER/OPQ lab. Ahmed joined FDA in ??2005 and has a Ph.D. in pharmaceutical sciences in Zagazig University, Egypt in collaboration ?with Howard university, USA. Dr Zidan is leading multiple research areas in FDA on evaluation ?of complex oral drug products manufactured by advanced technologies such as 3-dimensional ?printing and continuous manufacturing. Ahmed leads the topical and transdermal drug ?products laboratories of DPQR in OPQ and provides hands-on trainings to reviewers on various ?topics, including 3D printing, preformulation consideration for development of oral drug ?products, transdermal delivery systems and in vitro release and permeation testing of ?pharmaceuticals. Dr. Zidan is a member of the Additive manufacturing and Transdermal ?Working Groups of CDER and chaired several scientific lab events at CDER. Dr. Zidan is also an ?editorial board member of several pharmaceutical journals and published over 90 peer-?reviewed articles and book chapters.?